Edition:
United States

Edap Tms SA (EDAP.OQ)

EDAP.OQ on NASDAQ Stock Exchange Global Market

2.88USD
15 Dec 2017
Change (% chg)

$-0.01 (-0.35%)
Prev Close
$2.89
Open
$2.96
Day's High
$2.96
Day's Low
$2.88
Volume
2,997
Avg. Vol
13,337
52-wk High
$3.84
52-wk Low
$2.25

Chart for

About

EDAP TMS S.A. (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of... (more)

Overall

Beta: 1.00
Market Cap(Mil.): $84.20
Shares Outstanding(Mil.): 29.00
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 27.83 16.04
EPS (TTM): -- -- --
ROI: -- 10.00 34.69
ROE: -- 15.21 15.46

BRIEF-EDAP signs exclusive agreement with Theraclion to distribute Echopulse® in France

* EDAP signs exclusive agreement with Theraclion to distribute Echopulse® HIFU product in France

Oct 09 2017

BRIEF-Theraclion announces exclusive distribution agreement with EDAP TMS France

* THERACLION ANNOUNCES EXCLUSIVE DISTRIBUTION AGREEMENT WITH EDAP TMS FRANCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 09 2017

BRIEF-Edap announces FDA clearance of its Ablatherm-Fusion device

* Edap announces FDA clearance of its Ablatherm-Fusion® device

Oct 04 2017

BRIEF-Edap Tms SA submits new 510(k) application for its Focal One device

* Edap Tms SA - company submitted a new 510(k) application for its focal one device, including an updated clinical section for FDA review Source text for Eikon: Further company coverage:

Sep 11 2017

BRIEF-Edap announces filing of 510(k) application for Ablatherm-Fusion device

* Edap announces filing of 510(k) application for Ablatherm-Fusion device Source text for Eikon: Further company coverage:

Jul 31 2017

Competitors

Earnings vs. Estimates